Vega José M de Hoyos, Hong Hye Jin, Loutherback Kevin, Stybayeva Gulnaz, Revzin Alexander
Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Adv Mater Technol. 2023 Jan 24;8(2). doi: 10.1002/admt.202201121. Epub 2022 Oct 3.
Liver cultures may be used for disease modeling, testing therapies and predicting drug-induced injury. The complexity of the liver cultures has evolved from hepatocyte monocultures to co-cultures with non-parenchymal cells and finally to precision-cut liver slices. The latter culture format retains liver's native biomolecular and cellular complexity and therefore holds considerable promise for in vitro testing. However, liver slices remain functional for ~72 h in vitro and display limited utility for some disease modeling and therapy testing applications that require longer culture times. This paper describes a microfluidic device for longer-term maintenance of functional organotypic liver cultures. Our microfluidic culture system was designed to enable direct injection of liver tissue into a culture chamber through a valve-enabled side port. Liver tissue was embedded in collagen and remained functional for up to 31 days, highlighted by continued production of albumin and urea. These organotypic cultures also expressed several enzymes involved in xenobiotic metabolism. Conversely, matched liver tissue embedded in collagen in a 96-well plate lost its phenotype and function within 3-5 days. The microfluidic organotypic liver cultures described here represent a significant advance in liver cultivation and may be used for future modeling of liver diseases or for individualized liver-directed therapies.
肝脏培养可用于疾病建模、测试疗法以及预测药物性损伤。肝脏培养的复杂性已从肝细胞单培养发展到与非实质细胞的共培养,最终发展到精密肝切片。后一种培养形式保留了肝脏天然的生物分子和细胞复杂性,因此在体外测试方面具有很大潜力。然而,肝切片在体外仅能保持约72小时的功能,对于一些需要更长培养时间的疾病建模和疗法测试应用来说,其效用有限。本文描述了一种用于长期维持功能性器官型肝脏培养的微流控装置。我们的微流控培养系统旨在通过一个带阀门的侧端口将肝组织直接注入培养室。肝组织嵌入胶原蛋白中,并在长达31天的时间内保持功能,白蛋白和尿素的持续产生就是明证。这些器官型培养物还表达了几种参与异生物质代谢的酶。相反,嵌入96孔板胶原蛋白中的对照肝组织在3 - 5天内就失去了其表型和功能。本文所述的微流控器官型肝脏培养代表了肝脏培养方面的一项重大进展,可用于未来的肝脏疾病建模或个体化肝脏导向治疗。